US9028887B2ActiveUtilityA1

Method improve spatial memory via pterostilbene administration

Assignee: US AGRICULTUREPriority: Sep 7, 2007Filed: May 22, 2014Granted: May 12, 2015
Est. expirySep 7, 2027(~1.1 yrs left)· nominal 20-yr term from priority
A61P 39/06A61P 43/00A61K 31/09A61K 31/07A61K 36/45A61P 25/00A61P 25/28
55
PatentIndex Score
0
Cited by
3
References
7
Claims

Abstract

Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for increasing the spatial learning of a subject, the method comprising administrating to a subject in need thereof an effective amount of isolated or purified pterostilbene, wherein the spatial learning for a subject is increased. 
     
     
       2. The method as recited in  claim 1  wherein the effective amount of isolated or purified pterostilbene is about 10 mg of compound per kilogram of subject body weight. 
     
     
       3. The method of  claim 1  wherein pterostilbene is administered with a pharmaceutical carrier. 
     
     
       4. The method of  claim 1  wherein pterostilbene is administered with a nutraceutical carrier. 
     
     
       5. The method of  claim 1  wherein the effective amount of isolated or purified pterostilbene is an amount about 2.5 mg to about 10 mg of compound per kilogram of subject body weight. 
     
     
       6. The method of  claim 1  wherein the subject is afflicted with a neurodegenerative disease. 
     
     
       7. The method of  claim 6  wherein the neurodegenerative disease is Alzheimer's disease.

Join the waitlist — get patent alerts

Track US9028887B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.